BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
PBX1
,
glucose metabolic process
,
Influenza
,
Pancreas
,
DNA fingerprint
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
GIPR
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Granulocyte-macrophage progenitor cell of bone marrow
Plasma cell of spleen
Transverse colon
Macrophage of peripheral blood
Ascending colon
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Body mass index
Tinea pedis
Glucose level - finding
Toxoplasmosis
Effects of reduced temperature
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Peptides
Vecuronium Bromide
Glipizide
cortistatin A
Tubocurarine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
PCAT1
SLC16A2
PRKG1
CIRBP
GHRHR
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Genetic disruption of the Gipr in Apoe-/- mice promotes atherosclerosis.
Discovery of a potent GIPR peptide antagonist that is effective in rodent and human systems.
GIPR expression is induced by thiazolidinediones in a PPARĪ³-independent manner and repressed by obes…
Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms.
GIPR rs10423928 and bone mineral density in postmenopausal women in Shanghai.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Role of GIP and GLP-2 in Postprandial Splanchnic Blood Flow Distribution and Metabolism
Pharmacogenomics of GLP1 Receptor Agonists
Delinieation of GIP's Effects During a Meal in Humans Using GIP Receptor Antagonisation (GA-4)
Inhibition of the Endogenous GIP Response With a GIP Receptor Antagonist
Glucose-dependent Insulinotropic Polypeptide as a Safeguard Against Hypoglycemia in Patients With Ty…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ